Anti-tumour necrosis factor α therapy in rheumatoid arthritis: an update on safety
KL Hyrich, AJ Silman, KD Watson… - Annals of the Rheumatic …, 2004 - ard.bmj.com
Anti-tumour necrosis factor α therapy in rheumatoid arthritis: an update on safety | Annals of the
Rheumatic Diseases Skip to main content Viewing from: Google Indexer BMJ Journals …
Rheumatic Diseases Skip to main content Viewing from: Google Indexer BMJ Journals …
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated …
JB Galloway, KL Hyrich, LK Mercer, WG Dixon… - …, 2011 - academic.oup.com
Objectives. To evaluate the risk of serious infections (SIs) in patients with RA treated with
anti-TNF therapy with emphasis on the risk across different ages. Methods. Using data from …
anti-TNF therapy with emphasis on the risk across different ages. Methods. Using data from …
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register …
Background The risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA) is thought
to be increased following anti-tumour necrosis factor (anti-TNF) therapy, with a proposed …
to be increased following anti-tumour necrosis factor (anti-TNF) therapy, with a proposed …
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: results from the British …
Objective Rheumatoid arthritis (RA) is associated with an increased risk of coronary artery
disease, possibly acting via shared mechanisms of inflammation. This study was undertaken …
disease, possibly acting via shared mechanisms of inflammation. This study was undertaken …
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
KL Hyrich, KD Watson, AJ Silman… - …, 2006 - academic.oup.com
Background. Anti-tumour necrosis factor-α (TNF-α) therapies represent an important
advancement in therapy for rheumatoid arthritis (RA). However, there remains a proportion …
advancement in therapy for rheumatoid arthritis (RA). However, there remains a proportion …
Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: results from a …
KL Hyrich, M Lunt, KD Watson… - Arthritis & …, 2007 - Wiley Online Library
Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one
anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently …
anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently …
Low back pain in schoolchildren: occurrence and characteristics
KD Watson, AC Papageorgiou, GT Jones, S Taylor… - Pain, 2002 - journals.lww.com
Low back pain in adolescents is perceived to be uncommon in the clinic setting. However,
previous studies have suggested that it may be an important and increasing problem in this …
previous studies have suggested that it may be an important and increasing problem in this …
Predictors of low back pain in British schoolchildren: a population-based prospective cohort study
GT Jones, KD Watson, AJ Silman, DPM Symmons… - …, 2003 - publications.aap.org
Objective. To determine the onset of low back pain (LBP) in schoolchildren and to
investigate the role of mechanical and psychosocial factors as risk factors for its onset …
investigate the role of mechanical and psychosocial factors as risk factors for its onset …
Low back pain in schoolchildren: the role of mechanical and psychosocial factors
KD Watson, AC Papageorgiou, GT Jones… - Archives of disease in …, 2003 - adc.bmj.com
Background: Low back pain (LBP) in schoolchildren with no apparent clinical cause is
known to be a common problem, but considerably less is understood regarding the …
known to be a common problem, but considerably less is understood regarding the …
Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies
Objective In a recent observational study, we found that the risk of serious infection following
anti–tumor necrosis factor α (anti‐TNFα) therapy in patients with rheumatoid arthritis (RA) …
anti–tumor necrosis factor α (anti‐TNFα) therapy in patients with rheumatoid arthritis (RA) …